Gelteq Limited Ordinary Shares Total Liabilities
Gelteq Limited Ordinary Shares total liabilities. Based on the latest financial reports, Gelteq Limited Ordinary Shares (GELS) has total liabilities worth $5.92 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Gelteq Limited Ordinary Shares defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Gelteq Limited Ordinary Shares (2020–2025)
Total liabilities of Gelteq Limited Ordinary Shares from 2020 to 2025. This chart illustrates how Gelteq Limited Ordinary Shares's total liabilities have evolved over time, based on quarterly financial data.
Gelteq Limited Ordinary Shares Competitors by Total Liabilities
The table below lists competitors of Gelteq Limited Ordinary Shares ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bhakti Agung Propertindo
JK:BAPI
|
Indonesia | Rp292.66 Billion |
|
Combigene AB
ST:COMBI
|
Sweden | Skr4.30 Million |
|
Intertainment AG
XETRA:ITN
|
Germany | €11.77 Million |
|
Ladangbaja Murni PT Tbk
JK:LABA
|
Indonesia | Rp31.52 Billion |
|
Union Pioneer Public Company Limited
BK:UPF
|
Thailand | ฿144.96 Million |
|
ENEFI Energiahatekonysagi Nyrt
BUD:ENEFI
|
Hungary | Ft649.11 Million |
|
Shiva Mills Limited
NSE:SHIVAMILLS
|
India | Rs-924.96 Million |
Liability Composition Analysis (2020–2025)
This chart breaks down Gelteq Limited Ordinary Shares's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Gelteq Limited Ordinary Shares (GELS) total assets.
Liquidity & Leverage Metrics
Gelteq Limited Ordinary Shares Total Liabilities Ratios Explained
Gelteq Limited Ordinary Shares total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.09 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.42 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.29 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Gelteq Limited Ordinary Shares's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Gelteq Limited Ordinary Shares (2020–2025)
The table below shows the annual total liabilities of Gelteq Limited Ordinary Shares from 2020 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | $5.67 Million | +0.45% |
| 2024-06-30 | $5.65 Million | +47.17% |
| 2023-06-30 | $3.84 Million | +50.24% |
| 2022-06-30 | $2.55 Million | +533.24% |
| 2021-06-30 | $403.23K | +1.81% |
| 2020-06-30 | $396.04K | -- |
About Gelteq Limited Ordinary Shares
Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Austra… Read more